Profound Gastric Acid Inhibition: Advantages and Potential Hazards

References

• Jones D B, Howden C W, Burget D W, Kerr G D, Hunt R H. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120–1127
   PubMed Web of Science ®Google Scholar
• Scandinavian multicentre study. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. Scand J Gastroenterol 1984; 19: 882–884
   PubMed Web of Science ®Google Scholar
• Classen M, Damman H G, Domschke W, et al. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Hepatogastroenterol 1985; 32: 243–245
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Rune S J, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer. N Engl J Med 1985; 312: 958–961
   PubMed Web of Science ®Google Scholar
• Walan A. Clinical perspectives of drugs inhibiting acid secretion: H+K+-ATPase inhibitors. Scand J Gastroenterol 1986; 21(suppl 125)50–53
   Google Scholar
• Bardhan K D, Bianchi Porro G, Bose K, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986; 8: 408–413
   PubMed Web of Science ®Google Scholar
• Bigard M A, Isal J P, Galmiche J P, Ebrard F, Bader J P. Efficacité' comparéd de l'oméprazole et de la cimétidine dans le traitement de l'ulcère duodénal en poussée évolutive. Essai thérapeutique, contrôle multicentrique français. Gastroenterol Clin Biol 1987; 11: 753–757
   PubMedGoogle Scholar
• Archambault A P, Pare P, Bailey R J, et al. Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 1988; 94: 1130–1134
   PubMedGoogle Scholar
• Lauritsen K, Rune S J, Wulff H R, et al. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. Gut 1988; 29: 249–253
   PubMed Web of Science ®Google Scholar
• Walan A, Bader J P, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69–75
   PubMed Web of Science ®Google Scholar
• Barbara L, Saggiori A, Olsson J, Cisternino M, Franceschi M. Omeprazole 20 mg om and ranitidine 150 mg bd in the healing of benign gastric ulcers: an Italian multicentre study. Gut 1987; 28: A1341
   Web of Science ®Google Scholar
• Tytgat G NJ, Lamers C BHW, Hameeteman W, Jan-Sen J MBJ, Wilson J A. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Aliment Pharmacol Ther 1987; 1: 31–38
   PubMedGoogle Scholar
• Bardhan K D, Naesdal J, Bianchi Porro G, et al. Omeprazole in the treatment of refractory peptic ulcer. Gastroenterology 1988; 94: A22
   PubMedGoogle Scholar
• Brunner G, Creutzfeldt W, Harke U, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80–90
   PubMed Web of Science ®Google Scholar
• Gough K R, Korman M G, Bardhan K D, et al. Ranitidine and cimetidine in prevention of duodenal ulcer relapse: a double-blind, randomised, multicentre, comparative trial. Lancet 1984; 2: 659–662
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Jansen J MBJ, De Bruyne J W, et al. Longterm efficacy and safety of omeprazole on healing and prevention of resistant reflux esophagitis. Gastroenterology 1988; 94: A230
   Google Scholar
• Klinkenberg-Knol E C, Jansen J MBJ, Festen H PM, Meuwissen S GM, Lamers C BHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Coenegrachts J, Rutgeerts L, Schur-Mans P. Omeprazole (40 mg) is superior to ranitidine in the short-term treatment of ulcerative reflux esophagitis. Gastroenterology 1987; 92: 1681
   Web of Science ®Google Scholar
• Havelund T, Laursen L S, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in the treatment of reflux oesophagitis: double blind comparative trial. Br Med J 1988; 296: 89–92
   PubMed Web of Science ®Google Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Scand J Gastroenterol 1988; 23: 625–632
   PubMed Web of Science ®Google Scholar
• Lamers C BHW, Lind T, Moberg S, Jansen J MBJ, Olbe L. Omeprazole in Zollinger Ellison syndrome. N Engl J Med 1984; 310: 758–761
   PubMed Web of Science ®Google Scholar
• McArthur K E, Collen M J, Maton P W, et al. Omeprazole: effective convenient therapy for Zollinger Ellison syndrome. Gastroenterology 1985; 88: 939–944
   PubMedGoogle Scholar
• Ruddell W SJ, Axon A TR, Findlay J M, Bartholomew B A, Hill M J. Effect of cimetidine on the gastric bacterial flora. Lancet 1980; 1: 672–674
   PubMed Web of Science ®Google Scholar
• Muscroft T J, Youngs D, Burdon D W, Keighley M RB. Cimetidine and the potential risk of postoperative sepsis. Br J Surg 1981; 68: 557–559
   PubMed Web of Science ®Google Scholar
• Stockbruegger R W. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol 1985; 20(suppl 111)7–16
   Google Scholar
• Cook G C. Infective gastroenteritis and its relationship to reduced gastric acidity. Scand J Gastroenterol 1985; 20(suppl 111)17–21
   Google Scholar
• Howden C W, Hunt R H. Relationship between gastric secretion and infection. Gut 1987; 28: 96–107
   PubMed Web of Science ®Google Scholar
• Triger D R, Slater D N, Goepel J R, Underwood J CE. Systemic candidiasis complicating acute hepatic failure in patients treated with cimetidine. Lancet 1981; 2: 837
   PubMed Web of Science ®Google Scholar
• Du Moulin G C, Paterson D G, Hedley-Whyte J, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982; 1: 242–245
   PubMed Web of Science ®Google Scholar
• Driks M R, Craven D E, Celli B R, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 1987; 317: 1376–1382
   PubMed Web of Science ®Google Scholar
• Ruddell W SJ, Bone E S, Hill M J, Blendis L M, Walters C L. Gastric juice nitrite: a risk factor for cancer in the hypochlorhydric stomach?. Lancet 1976; 2: 1037–1039
   PubMed Web of Science ®Google Scholar
• Reed P I, Smith P LR, Haines K, House F R, Walters C L. Gastric juice N-nitrosamines in health and gas-troduodenal disease. Lancet 1981; 2: 550–552
   PubMed Web of Science ®Google Scholar
• Schlag P, Bockler R, Ulrich H, Peter M, Merkle P, Herfarth C. Are nitrite and N-nitroso compounds in gastric juice risk factors for carcinoma in the operated stomach?. Lancet 1980; 1: 727–729
   PubMed Web of Science ®Google Scholar
• Reed P I, Smith P LR, Haines K, House F R, Walters C L. Effect of cimetidine on gastric juice N-nitro-samine concentration. Lancet 1981; 2: 553–555
   PubMed Web of Science ®Google Scholar
• Milton-Thompson G J, Ahmet Z, Lightfoot N F, et al. Intragastric acidity, bacteria, nitrite and N-nitroso compounds before, during and after cimetidine treatment. Lancet 1982; 2: 1091–1095
   Google Scholar
• Sharma B K, Santana I A, Wood E C, et al. Intragastric bacterial activity and nitrosation before, during and after treatment with omeprazole. Br Med J 1984; 289: 717–719
   PubMed Web of Science ®Google Scholar
• Muscroft T J, Youngs D J, Burdon D W, Keighley M RB. Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet 1981; 1: 408–410
   PubMed Web of Science ®Google Scholar
• Hall C N, Darkin D, Brimblecombe R, Cook A J, Kirkham J S, Northfield T C. Evaluation of the nitro-samine hypothesis of gastric carcinogenesis in precancerous conditions. Gut 1986; 27: 491–498
   PubMedGoogle Scholar
• Binder H J, Donaldson R M. Effect of cimetidine of intrinsic factor and pepsin secretion. Gastroenterology 1978; 74: 371–375
   PubMed Web of Science ®Google Scholar
• Sharpe P C, Mills J G, Horton M A, Hunt R H, Vincent S H, Milton-Thompson G J. Histamine H2 receptors and intrinsic factor secretion. Scand J Gastroenterol 1980; 15: 377–384
   PubMed Web of Science ®Google Scholar
• Festen H, Tuynman H, Hollander W, Meuwissen S. Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action. Gut 1988; 29: A712
   Google Scholar
• Festen H, Tertoolen J. Malabsorption of protein-bound but not unbound cobalamin during treatment with omeprazole. Gastronenterology 1988; 94: A125
   Web of Science ®Google Scholar
• Steinberg W M, King C E, Toskes P P. Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration. Dig Dis Sci 1980; 25: 188–192
   PubMed Web of Science ®Google Scholar
• Walsh J H, Richardson C T, Fordtran J S. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462–468
   PubMed Web of Science ®Google Scholar
• Hansky J, Stern A I, Korman M G, Waugh J. Effects of long-term cimetidine on serum gastrin in duodenal ulcer. Dig Dis Sci 1979; 24: 468–470
   PubMed Web of Science ®Google Scholar
• Mahachai V, Walker K, Thomson A BR, et al. Comparison of cimetidine and ranitidine on 24-hour intragastric acidity and serum gastrin profile in patients with eosphagitis. Dig Dis Sci 1985; 30: 321–328
   PubMed Web of Science ®Google Scholar
• Lanzon-Miller S, Pounder R E, Hamilton M R, et al. Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther 1987; 1: 225–237
   PubMedGoogle Scholar
• Festen H PM, Thijs J C, Lamers C BHW, et al. The effect of oral omeprazole on serum gastrin and serum pesinogen I levels. Gastroenterology 1984; 87: 1030–1034
   PubMed Web of Science ®Google Scholar
• Ekman L, Hansson E, Havu N, Carlsson E, Lund-Berg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20(suppl 108)53–69
   Google Scholar
• Blom H. Effects of omeprazole on normal and regenerating gastric mucosa in the rat. A light and electron microscopy study. Scand J Gastroenterol 1986; 21(suppl 118)70–71
   PubMedGoogle Scholar
• Larsson H, Carlsson E, Mattsson H, et al. Plasma gastrin and gastrin enterochromaffin like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 391–399
   PubMed Web of Science ®Google Scholar
• Lamberts R, Creutzfeldt W, Stockman F, Jacu-Baschke U, Maas S, Brunner G. Long-term omeprazole treatment in man: effects on gastric endocrine cell population. Digestion 1988; 39: 126–135
   PubMed Web of Science ®Google Scholar
• Larsson L I, Rehfeld R F, Stockbriigger R, et al. Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin. Am J Pathol 1978; 93: 53–68
   PubMed Web of Science ®Google Scholar
• Harvey R F, Bradshaw M J, Davidson C M, Wilkinson S P, Davies P S. Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia. Lancet 1985; 1: 951–953
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985; 88: 638–648
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Kullman E, Wilander E. Gastrie carcinoid associated with the syndrome of hyper-gastrinemic atrophic gastritis. Am J Surg Pathol 1987; 11: 435–444
   PubMed Web of Science ®Google Scholar
• Bardram L, Thomsen P, Stadil F. Gastric endocrine cells in omeprazole treated and untreated patients with the Zollinger-EUison syndrome. Digestion 1986; 35(suppl 1)116–122
   PubMedGoogle Scholar
• Creutzfeldt W, Stockman F, Conlon J M, Folsch U R, Bonatz G, Wulfrath M. Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion 1986; 35(suppl 1)84–97
   PubMed Web of Science ®Google Scholar
• Larsson H, Carlsson E, Hakanson R, et al. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion: studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1988; 95: 1477–1486
   PubMed Web of Science ®Google Scholar
• Sharma B, Axelson M, Pounder R, et al. Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects. Aliment Pharmacol Ther 1987; 1: 67–76
   PubMedGoogle Scholar
• Lamers C BHW, Jansen J BMJ. Invloed van gastro-intestinale hormonen op carcinomen van het maag-darmkanaal. Ned Tijdschr Geneeskd 1988; 132: 151–154
   PubMedGoogle Scholar
• Kobori O, Vuillot M T, Martin F. Growth response of rat stomach cancer cells to gastro-enteropan-creatic hormones. Int J Cancer 1982; 30: 65–67
   PubMed Web of Science ®Google Scholar
• McGregor D B, Jones R D, Karlin D A, Romsdahl M M. Trophic effects of gastrin on colorectal neoplasms in the rat. Ann Surg 1982; 195: 219–223
   PubMed Web of Science ®Google Scholar
• Sumiyoshi H, Yasui W, Ochiai A, Tahara E. Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res 1984; 44: 4276–4280
   PubMed Web of Science ®Google Scholar
• Palmer Smith J, Solomon T E. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 1988; 95: 1541–1548
   PubMed Web of Science ®Google Scholar
• Forrest J AH, Fettes M R, McLoughlin G P, Heading R C. Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. Gut 1979; 20: 404–407
   PubMed Web of Science ®Google Scholar